Cumberland Pharmaceuticals (CPIX) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to -$25.4 million.
- Cumberland Pharmaceuticals' Retained Earnings fell 1508.44% to -$25.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.4 million, marking a year-over-year decrease of 1508.44%. This contributed to the annual value of -$24.0 million for FY2024, which is 3705.23% down from last year.
- Latest data reveals that Cumberland Pharmaceuticals reported Retained Earnings of -$25.4 million as of Q3 2025, which was down 1508.44% from -$23.5 million recorded in Q2 2025.
- In the past 5 years, Cumberland Pharmaceuticals' Retained Earnings registered a high of -$735625.0 during Q2 2021, and its lowest value of -$25.4 million during Q3 2025.
- Moreover, its 5-year median value for Retained Earnings was -$11.2 million (2023), whereas its average is -$13.3 million.
- Over the last 5 years, Cumberland Pharmaceuticals' Retained Earnings had its largest YoY gain of 390.27% in 2021, and its largest YoY loss of 138567.17% in 2021.
- Over the past 5 years, Cumberland Pharmaceuticals' Retained Earnings (Quarter) stood at -$5.6 million in 2021, then tumbled by 98.79% to -$11.2 million in 2022, then plummeted by 56.02% to -$17.5 million in 2023, then tumbled by 37.05% to -$24.0 million in 2024, then dropped by 5.94% to -$25.4 million in 2025.
- Its Retained Earnings stands at -$25.4 million for Q3 2025, versus -$23.5 million for Q2 2025 and -$22.7 million for Q1 2025.